Nephros Inc
NASDAQ:NEPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nephros Inc
NASDAQ:NEPH
|
US |
|
Industria de Diseno Textil SA
MAD:ITX
|
ES |
|
CTT Systems AB
STO:CTT
|
SE |
|
G50 Corp Ltd
OTC:GFTYF
|
AU |
|
Chimerix Inc
NASDAQ:CMRX
|
US |
|
Montero Mining and Exploration Ltd
XTSX:MON
|
CA |
|
H
|
Healthpeak Properties Inc
F:HC5
|
US |
|
M
|
MPM Technologies Inc
OTC:MPML
|
US |
|
Aptech Ltd
NSE:APTECHT
|
IN |
Wall Street
Price Targets
NEPH Price Targets Summary
Nephros Inc
According to Wall Street analysts, the average 1-year price target for
NEPH
is 7.14 USD
with a low forecast of 6.06 USD and a high forecast of 8.4 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is NEPH's stock price target?
Price Target
7.14
USD
According to Wall Street analysts, the average 1-year price target for
NEPH
is 7.14 USD
with a low forecast of 6.06 USD and a high forecast of 8.4 USD.
What is Nephros Inc's Revenue forecast?
Projected CAGR
11%
For the last 14 years the
compound annual growth rate for
Nephros Inc's revenue is
17%.
The projected
CAGR
for the next 2 years is
11%.
What is Nephros Inc's Operating Income forecast?
Projected CAGR
18%
The
compound annual growth rate
of
Nephros Inc's operating income for the next 2 years is
18%.
What is Nephros Inc's Net Income forecast?
Projected CAGR
38%
The
compound annual growth rate
of
Nephros Inc's net income for the next 2 years is
38%.